Staci L. Vernick
Staci Vernick is a contributing health and science writer. With expertise in healthcare, medical and science communications and a passion for evocative storytelling, Staci has directed communications for academic medical centers and biomedical research organizations, including Johns Hopkins Children’s, The Wistar Institute and the American Association for Cancer Research. A former journalist, she has written on topics ranging from children’s health to cancer biology to health policy.
Health Lab
Returning to normal life after heart failure through LVAD therapy
Thirty-one-year-old is not letting his heart diagnosis define his life or his future.
Illuminate
Engineering Better Colorectal Cancer Outcomes
Meet Calista Harbaugh, MD, MSc, an assistant professor of surgery at the Rogel Cancer Center who strives to improve treatment outcomes for her colorectal cancer patients.
Illuminate
Tackling Pancreatic Cancer, Bench to Bedside
Learn how Dr. Eileen Carpenter's translational research laboratory studies pancreatic cancer at the molecular level—how it develops, metastasizes and becomes resistant to therapy. The goal is to identify new therapeutic targets and strategies to overcome chemoresistance so patients may live longer, healthier lives.
Health Lab
Roy’s Michigan Answer: Second opinion saves patient’s heart
Michigan Medicine's team of cardiology experts offered an advanced, minimally invasive coronary intervention, which restored one patient back to good health
Health Lab
Planting a tree, and hope, for a heart healthy future
A complex mitral valve repair by Michigan Medicine cardiac specialists helps restore health and happiness to one Michigan patient and his family.
Health Lab
Getting ahead of aortic disease
Patient bypasses a life threatening aortic aneurysm with the help of Michigan Medicine's genetic counseling and a streamlined cardiac referral program.
Illuminate
Cracking the Code of RNA
Meet Dr. Amanda Garner and learn how the Garner Lab at Rogel is celebrating its 10th year working at one of the final frontiers in drug discovery—the search for and development of RNA-targeted therapeutics for cancer and other diseases.
Illuminate
Uncovering Cancer's Roots in Chromatin
Learn about the Parolia Lab—or PARLAB — which studies the role of chromatin in cancer and how its architecture may be exploited to develop new therapies. Chromatin is the tightly wound package of DNA and proteins in the nucleus of every human cell that drives transcription and gene expression.
Health Lab
A unique collaboration helps one patient better manage aortic disease
MI-AORTA is a donor-funded initiative that facilitates collaboration within the Frankel Cardiovascular Center, U-M Health and referring provider networks, creating value for the patients, families, and communities they serve and allows them to continue to pioneer advanced therapies for aortic diseases.
Health Lab
Beating the odds against chronic total occlusion
Learn about the latest advances in treatment for chronic total occlusion, a life-threatening condition that deprives the heart of oxygen. A team of cardiovascular surgeons perform advanced, minimally invasive surgery to help David Schneider get his life back on track.
Health Lab
Researchers zero in on therapeutic target for aggressive uterine cancer
A common mutation in a rare cancer subtype leads researchers to an already-approved drug that shows promise against uterine serous carcinoma
